0001140361-14-022477.txt : 20140521 0001140361-14-022477.hdr.sgml : 20140521 20140521160623 ACCESSION NUMBER: 0001140361-14-022477 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20140521 DATE AS OF CHANGE: 20140521 EFFECTIVENESS DATE: 20140521 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Atea Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001593899 IRS NUMBER: 460574869 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-207797 FILM NUMBER: 14860767 BUSINESS ADDRESS: STREET 1: 2 AVERY STREET, SUITE 21E CITY: BOSTON STATE: MA ZIP: 02110 BUSINESS PHONE: 857-204-8109 MAIL ADDRESS: STREET 1: 2 AVERY STREET, SUITE 21E CITY: BOSTON STATE: MA ZIP: 02110 D/A 1 primary_doc.xml X0707 D/A LIVE 0001593899 Atea Pharmaceuticals, Inc. 125 Summer Street BOSTON MA MASSACHUSETTS 02110 857-204-8109 DELAWARE None None Corporation true 2012 Jean-Pierre Sommadossi, Ph.D. 125 Summer Street Boston MA MASSACHUSETTS 02110 Executive Officer Director Other Decline to Disclose 06b true 0001140361-13-045616 2013-12-30 false true false 100000 Madding King None Brookline Group, LLC 153587 2501 20th Place South Suite 275 Birmingham AL ALABAMA 35223 AL ALABAMA AR ARKANSAS AZ ARIZONA CA CALIFORNIA CO COLORADO CT CONNECTICUT DC DISTRICT OF COLUMBIA DE DELAWARE FL FLORIDA GA GEORGIA ID IDAHO IL ILLINOIS IN INDIANA KS KANSAS LA LOUISIANA MA MASSACHUSETTS MD MARYLAND MI MICHIGAN MN MINNESOTA MO MISSOURI MS MISSISSIPPI NC NORTH CAROLINA NE NEBRASKA NJ NEW JERSEY NM NEW MEXICO NV NEVADA NY NEW YORK OH OHIO OK OKLAHOMA OR OREGON PA PENNSYLVANIA RI RHODE ISLAND SC SOUTH CAROLINA TN TENNESSEE TX TEXAS UT UTAH VA VIRGINIA WA WASHINGTON WI WISCONSIN WV WEST VIRGINIA WY WYOMING false 20000000 14740000 5260000 false 43 0 0 Brookline Group, LLC will receive a cash fee equal to 8% and an equity fee payable in common stock equal to 6% of the gross offering proceeds received by the Company from investors introduced by Brookline. 0 false Atea Pharmaceuticals, Inc. /s/ Jean-Pierre Sommadossi Jean-Pierre Sommadossi Chief Executive Officer 2014-05-21